enGene Therapeutics Inc. (ENGN) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $167.71M | -38.5% |
| 2024 | $272.61M | +276.1% |
| 2023 | $72.49M | +194.6% |
| 2022 | -$76.61M | -43.4% |
| 2021 | -$53.44M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $167.71M | -38.5% |
| 2024 | $272.61M | +276.1% |
| 2023 | $72.49M | +194.6% |
| 2022 | -$76.61M | -43.4% |
| 2021 | -$53.44M | — |